drugset / Trial / NCT02206165
A Dose Selection Trial of CKD-330 in Patients With Essential Hypertension
RandomizedFactorialDouble-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of Candesartan/Amlodipine combined or alone and select better dose of CKD-330 in essential hypertension patients.
Timeline
- Start
- 2014-03
- Primary completion
- 2015-04
- Completion
- 2015-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amlodipine | Other / unclassified | 5 mg | Oral |
| Subject | Amlodipine | Other / unclassified | 10 mg | Oral |
| Subject | Candesartan | Unknown | 8 mg | Oral |
| Subject | Candesartan | Unknown | 16 mg | Oral |